Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0428 | 0.2576 | 0.3708 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0398 | 0.2258 | 0.2941 |
Leishmania major | hypothetical protein, conserved | 0.0181 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0243 | 0.0647 | 0.0864 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0502 | 0.3337 | 0.4398 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0562 | 0.3971 | 0.5305 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0639 | 0.4773 | 0.6376 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0602 | 0.4383 | 0.5834 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.1085 | 0.9418 | 1 |
Mycobacterium ulcerans | thioesterase TesA | 0.0502 | 0.3337 | 0.443 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.039 | 0.218 | 0.2574 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0562 | 0.3971 | 0.3889 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0583 | 0.4191 | 0.5599 |
Mycobacterium ulcerans | polyketide synthase | 0.0639 | 0.4773 | 0.6357 |
Mycobacterium ulcerans | thioesterase | 0.0502 | 0.3337 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0492 | 0.324 | 0.4329 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0398 | 0.2258 | 0.2981 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.09 | 0.7486 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0484 | 0.3157 | 0.4188 |
Loa Loa (eye worm) | fatty acid synthase | 0.0594 | 0.43 | 0.4318 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0639 | 0.4773 | 0.6337 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0207 | 0.0267 | 0.0356 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.09 | 0.7486 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0639 | 0.4773 | 0.6357 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0602 | 0.4383 | 0.581 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.09 | 0.7486 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0432 | 0.2616 | 0.3495 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0602 | 0.4383 | 0.5834 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0639 | 0.4773 | 0.6376 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0602 | 0.4383 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0602 | 0.4383 | 0.581 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0189 | 0.0081 | 0.0056 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0602 | 0.4383 | 0.5856 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0602 | 0.4383 | 0.4383 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0721 | 0.5621 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0484 | 0.3157 | 0.4188 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0181 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0502 | 0.3337 | 0.4459 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0639 | 0.4773 | 0.6337 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0342 | 0.1676 | 0.224 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0639 | 0.4773 | 0.6337 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0189 | 0.0081 | 0.0108 |
Giardia lamblia | Methyltransferase like 2 | 0.0181 | 0 | 0.5 |
Onchocerca volvulus | 0.1048 | 0.9028 | 0.9285 | |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0639 | 0.4773 | 0.6357 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0602 | 0.4383 | 0.5834 |
Brugia malayi | AMP-binding enzyme family protein | 0.0562 | 0.3971 | 0.3971 |
Mycobacterium tuberculosis | Polyketide synthetase MbtD (polyketide synthase) | 0.0185 | 0.0039 | 0.0052 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0602 | 0.4383 | 0.5856 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0639 | 0.4773 | 1 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0398 | 0.2258 | 0.2981 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0602 | 0.4383 | 0.5856 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0721 | 0.5621 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0484 | 0.3157 | 0.4155 |
Loa Loa (eye worm) | hypothetical protein | 0.0337 | 0.1625 | 0.0823 |
Brugia malayi | AMP-binding enzyme family protein | 0.0185 | 0.0039 | 0.0039 |
Mycobacterium ulcerans | polyketide synthase | 0.0602 | 0.4383 | 0.5834 |
Loa Loa (eye worm) | hypothetical protein | 0.1011 | 0.8648 | 1 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.09 | 0.7486 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0639 | 0.4773 | 0.6376 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0583 | 0.4191 | 0.5599 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0721 | 0.5621 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ratio (binding) | = 0.889 | Inhibition of human neuraminidase2 using 4-MU-NANA as substrate assessed as residual activity at 100 uM preincubated for 15 mins prior addition of substrate measured after 5 mins by fluorimetry relative to control in presence of 125 uM EDTA | ChEMBL. | 22410247 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.